Lundbeckfonden Emerge

Lundbeckfonden Emerge functions as an evergreen investor within the larger Lundbeck Foundation, dedicated to identifying and fostering the commercial development of promising scientific advancements. It specializes in translating early-stage research into novel therapeutics, primarily focusing on the biotechnology sector. The initiative employs a proactive approach to scouting opportunities, aiming to bridge the gap between academic discovery and market-ready solutions in healthcare.

Established in 2012 by the Lundbeck Foundation, Lundbeckfonden Emerge was formed with the strategic insight to cultivate and invest in nascent biotech ventures originating from Danish research. This creation aimed to build an internal mechanism for directly supporting the innovation ecosystem, drawing on the Foundation's extensive experience in healthcare and life sciences to nurture high-potential projects from their earliest stages.

Lundbeckfonden Emerge serves a diverse set of beneficiaries, including universities, hospitals, and emerging biotech companies, by actively collaborating with talented researchers and entrepreneurs. Its overarching mission is to improve global health by accelerating the development of groundbreaking science into impactful treatments, with a significant emphasis on addressing brain-related disorders and advancing the future of pharmaceutical innovation.